GlassScriptPhysician profile
Vicky A Oros
NPI 1912997719
$3,949.06
in general payments reported to CMS, 2019-2025
16 companies · $978 in 2025
The $978 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $242 · 2022: $672 · 2023: $1,244 · 2024: $813 · 2025: $978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,937 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,936.65 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $689.05 | 2022-2025 | Datroway, Enhertu |
| Janssen Biotech, INC. | $419.34 | 2022-2025 | Carvykti, Rybrevant |
| Emd Serono, INC. | $373.75 | 2023-2024 | Tepmetko |
| Gilead Sciences, INC. | $369.15 | 2023-2024 | Trodelvy |
| Incyte Corporation | $366.59 | 2021-2023 | Monjuvi, Jakafi |
| Jazz Pharmaceuticals INC. | $243.56 | 2024-2025 | |
| Beigene USA, INC. | $223.15 | 2023 | Brukinsa |
| Alexion Pharmaceuticals, INC. | $214.06 | 2021-2024 | |
| Sobi, INC | $211.71 | 2025 | |
| Abbvie INC. | $208.52 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $122.54 | 2022 | |
| Merck Sharp & Dohme LLC | $118.68 | 2023 | Keytruda |
| Seagen INC. | $105.80 | 2023 | Adcetris |
| Kite Pharma, INC. | $104.17 | 2023 | |
| Genzyme Corporation | $90.64 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $88.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicky Oros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.